企業プロフィール
Lisata Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- LSTA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.47 USD (-1.34%)
終値
最終更新: 2026年10月2日
31.7M USD
時価総額
株価変動の要因
最新のモニタリング対象企業ニュースは「Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for…」です。対応する終値の反応はまだ確認できません。
企業概要
事業概要
Lisata Therapeutics is a precision oncology company focused on therapies designed to improve tumor penetration and enhance drug delivery into solid tumors. Its story is built around the idea that better access to tumors can improve the performance of other anti-cancer approaches.
所在地とセクター分類
Lisata is headquartered in the United States and listed on NASDAQ, with a small-cap oncology biotechnology profile. It sits in the development-stage cancer and drug-delivery segment.
ビジネスモデルの特徴
The company depends on clinical data, partnership potential, and the ability to prove that its platform can improve outcomes in solid tumors. Investors generally watch trial updates, strategic collaborations, and capital needs.
バイオ業界での位置付け
Lisata occupies a specialized precision-oncology niche within biotech. The stock is driven by the market's view of whether its delivery-focused strategy can create meaningful clinical differentiation.
今後のカタリスト
- Lisata’s catalysts are certepetide and the pancreatic-cancer / solid-tumor development path, where the next update matters a lot. The company still needs stronger clinical proof.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。